Investors & Media
Stock Info
NASDAQBCLI
Company Information
BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Alzheimer’s Disease (AD).
BrainStorm Presentation on New Biomarker Data - NurOwn® at the 32nd International Symposium on ALS/MND
Brainstorm’s December 7, 2021 Presentation on new Biomarker data at the 32nd International Symposium on ALS/MND.
Tools
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds